Trial date set for men who allegedly sold Mac Miller drugs laced with fentanyl
The rapper passed away in 2018
A trial date has been set for the men accused of selling Mac Miller the drugs that killed him.
Miller, real name Malcom McCormick, passed away on September 7, 2018, at 26 from “mixed drug toxicity” according to a coroner’s report. His system was found to contain fentanyl, cocaine and alcohol.
Cameron James Pettit, Andrew Walter and Ryan Michael Reavis were charged with selling cocaine, oxycodone and Xanax to Miller in 2019. Two days before he died, Miller bought a mix of substances, including the three the men were charged for selling.
Read this next: One in 10 UK teens has tried hard drugs by 17, according to new study
Nick Hanna, US Attorney, claimed that the defendants had “allegedly continued to sell narcotics after Mr McCormick’s death with full knowledge of the risk of their products”.
In a statement, Hanna noted: “It has become increasingly common for us to see drug dealers peddling counterfeit pharmaceuticals made with fentanyl,”. She continued on to say that “As a consequence, fentanyl is now the number one cause of overdose deaths in the United States.”
The three defendants have pleaded not guilty.
Read this next: New survey finds that 88.3% of people think drugs are becoming easier to obtain
A book, Most Dope: The Extraordinary Life of Mac Miller recounting Miller’s life is set to be released next year, but his family have urged against buying the book:
“This book is not authorised or endorsed by Malcolm’s family and has been written by a writer with whom Malcolm did not have a relationship,” a statement read. “The writer of this book was made aware at the outset of the process of writing this book that the family and friends of Malcolm were uncomfortable with him authoring this biography, yet he chose to proceed against our polite insistence that he not do disservice to Malcolm’s legacy through writing a book without legitimate primary sources.”
[Via: NME]
Tope Olufemi is Mixmag's Digital Intern, follow them on Twitter here
Mixmag will use the information you provide to send you the Mixmag newsletter using Mailchimp as our marketing platform. You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us. By clicking sign me up you agree that we may process your information in accordance with our privacy policy. Learn more about Mailchimp's privacy practices here.
